papilledema and intracranial hypertension–papilledema (disc edema from raised icp) • idiopathic...
TRANSCRIPT
©2014 MFMER | slide-1
Papilledema and Intracranial Hypertension
John J. Chen, MD, PhDNeuro-Ophthalmology
Nebraska Academy of Eye Physicians and Surgeons Fall Scientific Meeting September 20, 2019
©2014 MFMER | slide-2
DISCLOSUREJohn J. Chen, M.D., Ph.D.
Relevant Financial Relationship(s)
None
Off Label Usage
MR elastography
Presentation Learning Objectives
• Discuss the most common causes of papilledema and workup
Presentation Learning Objectives
• Describe the diagnosis and treatment of idiopathic intracranial hypertension
• Describe common mimickers of papilledema (pseudopapilledema)
• Discuss tools for detecting and following papilledema (including recent/future studies)
©2014 MFMER | slide-5
Case #1: Classic case of idiopathic intracranial hypertension
• 23 yo female presented with headaches
– Also c/o hearing her heart beat in her ears (pulse
synchronous tinnitus)
– Also episodes of vision blacking out a couple of
seconds at a time (transient visual obscurations)
– Gained 30lb over the past 6 months, BMI 35
©2014 MFMER | slide-6
20/20 OU
©2014 MFMER | slide-7
Next step?
• Neuroimaging or LP first?
• What kind of imaging?
©2014 MFMER | slide-8
Next step?
• Neuroimaging or LP first? Neuroimaging BEFORE LP
• What kind of imaging?
©2014 MFMER | slide-9
Next step?
• Neuroimaging or LP first? Neuroimaging BEFORE LP
• What kind of imaging? MRI/MRV
©2014 MFMER | slide-10
Sagittal T1 MRI MRV
©2014 MFMER | slide-11
Case #1
• Lumbar puncture
– opening pressure of 390mm H20 (normal is <250)
– Normal CSF constituents
• Diagnosis:
– Idiopathic intracranial hypertension (IIH)
or pseudotumor cerebri
©2014 MFMER | slide-12
Idiopathic intracranial hypertension (IIH)
• Signs and symptoms of increased intracranial
pressure
• No localizing neurologic findings (Cranial nerve
VI palsies are allowed)
• Normal neuroimaging (with the exception of
indirect signs of raised ICP)
• Opening pressure of lumbar puncture of
greater than 250 mm water, with normal CSF
• No other cause of increased intracranial
pressure present
• DIAGNOSIS OF EXCLUSION
©2014 MFMER | slide-13
Symptoms
Pulse synchronous tinnitus
Transient visual obscurations
Headaches
Horizontal diplopia (6th nerve palsies)
Associated with:
Vitamin A toxicity, retinoic acid, ATRA, tetracyclines, lithium, withdrawal
from steroids, possibly sleep apnea
Obesity
>90% have BMI >30
>50% have BMI >40
Female sex
♀:♂ ≈ 10:1
Child-bearing age
• Incidence 3.3/100K in all women
• 6.8/100K in women 15-44 years old
• 22.0/100K in obese women 15-44 years old
Idiopathic intracranial hypertension (IIH)
©2014 MFMER | slide-14
Incidence has more than
doubled over the past 20 yrs.
Now 2.4 per 100,000
22 per 100,000 in obese
young adult females
©2014 MFMER | slide-15
Idiopathic intracranial hypertension (IIH)
• Neuroimaging needed to r/o tumor,
hydrocephalus, meningeal lesion, cerebral
venous sinus thrombosis
– Indirect signs of raised ICP
• Empty sella, flattened globe, enlarged optic nerve sheaths,
narrowing of the transverse sinus
• LP to rule out infectious, inflammatory, or
neoplastic process
©2014 MFMER | slide-16
IIH treatment
• Permanent vision loss in up to 40% of patients
• Treatment
– Serial follow-up with visual fields is important
– Weight loss
– Acetazolamide or topiramate
– Optic nerve sheath fenestration or VP shunt for
vision threatening disease
©2014 MFMER | slide-17
IIH treatment trial (IIHTT)
• VF mean deviation
-2 to -7 db
• Randomized to
acetazolamide or
placebo
– 500 mg bid titrated
to 4000 mg/day
– All pts diets
w/personal weight
coaches
IIHTT Conclusions
0 1 2 3 4 5 6
-2.0
-1.5
-1.0
-0.5
0.0
Month
M
ean
Cha
nge
in F
rise
n G
rade
(Wor
st E
ye)
0 1 2 3 4 5 6
-2.0
-1.5
-1.0
-0.5
0.0
Month
M
ean
Cha
nge
in F
rise
n G
rade
(Wor
st E
ye)
Acetazolamide + diet
Placebo + diet
Acetazolamide + diet
Placebo + diet
Change in Papilledema
Grade in Worse EyeJAMA. 2014;311(16):1641-1651
Change in PMD in Worse Eye
Acetazolamide improved
visual field function
Acetazolamide improved
papilledema grade
©2014 MFMER | slide-19
• Acetazolamide well tolerated up to 4 grams/day (44% of patients)
• Side effects common: paresthesias, dysgeusia, vomiting/diarrhea, nausea, fatigue
• Serial lab monitoring, potassium supplementation not required
J. Neuro- Ophthalmology . 2016;36:13–19
©2014 MFMER | slide-20
M Wall, et al. Neurology 2015;85:799–805
• 7 patients
• 6 in placebo arm
• Higher grade papilledema (grade 3-5)
• Decreased acuity
• Male gender
• >30 transient visual obscurations per month
©2014 MFMER | slide-21
Headache. 2017;57(8):1303-10
https://www.nordicclinicaltrials.com/wicket/bookmarkable/org.slr.nordic.webapp.
cms.DisplayScheduledContent?id=12
©2014 MFMER | slide-22
Already 24 articles and 4 editorials/letters from the IIHTT
©2014 MFMER | slide-23
Surgery for IIH
• Surgery for IIH in 3 main scenarios:
– 1. Fulminant IIH with vision threatening disease
– 2. Extended period of max medical therapy and
weight loss with persistent disc edema
– 3. Significant papilledema with functional overlay
• Role of venous sinus stenting?
©2014 MFMER | slide-24
Venous stenting for IIH
Preliminary data for venous sinus stenting is promising
©2014 MFMER | slide-25
Terminology of disc edema
• Disc edema: disc swelling from any cause
– Includes papilledema, NAION, optic neuritis
• Papilledema: disc edema from raised
intracranial pressure
– Usually intact vision with full fields other than
enlarged blind spots
• Pseudopapilledema: anomalous nerves or
optic nerve drusen that mimic the appearance
of disc edema
©2014 MFMER | slide-26
Case #2
• 44 yo female with headaches, pulse
synchronous tinnitus, and transient visual
obscurations
©2014 MFMER | slide-27
20/20 OU
©2014 MFMER | slide-28
Cerebral venous sinus thrombosis
• MRV or CTV is important in the setting of
papilledema to r/o venous sinus thrombosis
• Cerebral venous sinus thrombosis can cause
stroke
• Treatment with anticoagulation
©2014 MFMER | slide-29
54yo female presents with bilateral papilledema and headaches
20/20 OU
MRI/MRV brain
are normal
©2014 MFMER | slide-30
Lumbar puncture
• Opening pressure: 320 mm H2O
• 12 white cells (32% neutrophils, 66%
lymphocytes)
• Glucose 104mg/dl
• Protein >300mg/dl (nl <35)
• Cytology negative
©2014 MFMER | slide-31
Imaging of the spinal cord
©2014 MFMER | slide-32
Melanocytic
meningeal neoplasm
Imaging of the spinal cord
Dissemination of tumor cells
Elevated CSF protein and protein degradation products
=> CSF obstruction (decreased CSF absorption)
IIH is a diagnosis of exclusion that
requires MRI/MRV and lumbar puncture
Courtesy of
Valerie Biousse
©2014 MFMER | slide-33
24yo female with headaches. 20/20 OU. Full fields
BP 220/120: Malignant hypertension
Must check blood pressure. IIH is a diagnosis of exclusion!
©2014 MFMER | slide-34
Malignant hypertension
©2014 MFMER | slide-35
• 8 year old girl referred for bilateral disc edema.
Optic disc drusen(pseudopapilledema)
©2014 MFMER | slide-36
Example of prominent calcified drusen in an older patient
36 yo female referred
for disc edema
OCT shows a small disc area and normal/thin RNFL thickness: pseudopapilledema
©2014 MFMER | slide-38
Differentiating pseudopapilledema from papilledema
True disc edema: Paton’s lines, choroidal folds, hyperemia, hemorrhages, loss of
spontaneous venous pulsations, obscuration of vessels, leakage on fluorescein
©2014 MFMER | slide-39
18 yo female with headaches x 6 months, no other sx of raised ICP.
Ultrasound negative for drusen.
Imaging unremarkable, LP with an opening pressure of 22 cm H20
True disc edema or anomalous nerves?
©2014 MFMER | slide-40
Mild IIH confirmed by improvement in the disc edema in response to acetazolamide
Treated with acetazolamide. 3 month f/u
©2014 MFMER | slide-41
23 yo female c/o headaches. Denies changes in vision. 20/20 OU
©2014 MFMER | slide-42
• MRI/MRV showed no abnormalities.
• LP showed an opening pressure of 320mmH20
– Confirms IIH
• Asymmetric papilledema in IIH
– 10% of IIH has asymmetric papilledema (interocular
difference of ≥2 grades)
©2014 MFMER | slide-43
78 yo male referred for disc edema in the right eye
Vitreopapillary traction can cause pseudopapilledema
©2014 MFMER | slide-44
51 yo male with diabetes, HTN, HLD, sleep apnea.
20/20 OU. MRI/MRV were normal.
Incipient NAION in the left eye
©2014 MFMER | slide-45
4 months later. 20/20 OU
Incipient NAION in the right eye
©2014 MFMER | slide-46
Incipient NAION vs. diabetic papillitis
• Likely the same disease process
• Disc edema with preserved vision
• Mild, reversible ischemia
• Can progress to ischemic optic neuropathy
with permanent vision loss in 25% of cases
©2014 MFMER | slide-47
Swollen optic nerve with preserved vision
– Papilledema (disc edema from raised ICP)
• Idiopathic intracranial hypertension (need MRI/MRV and LP)
• Intracranial hypertension
– Tumor, meningitis, venous sinus thrombosis, obstructive
hydrocephalus, etc
– Malignant hypertension
– Incipient NAION or diabetic papillitis
– Optic perineuritis (ex. syphilis)
– Pseudopapilledema
• Optic disc drusen
• Small little red disc or anomalous optic nerve
• Myelinated nerve fiber
• Vitreopapillary traction
©2014 MFMER | slide-48
Idiopathic intracranial hypertension without papilledema?
If you can have unilateral papilledema, you can likely have IIH without papilledema
Unilateral papilledema from IIH
However, you cannot make a definite diagnosis of IIH without papilledema
©2014 MFMER | slide-49
Idiopathic intracranial hypertension without papilledema?
Friedman, Liu, Digre 2013
Without papilledema or
6th nerve palsy, the
diagnosis can only be
suggested.
3 indirect signs of raised
ICP are required to make
that suggestion.
©2014 MFMER | slide-50
Fisayo A, Bruce BB, Newman NJ, Biousse V. Neurology. 2015 Dec 30
39.5% referred for IIH did not have the diagnosis
©2014 MFMER | slide-51
Current methods of measuring intracranial pressure
• Lumbar puncture
– Invasive and variable
– Valsalva can cause a 5 fold increase in opening
pressure
• Direct intracranial pressure monitoring
– Gold standard: intraventricular catheter
– Invasive and requires hospitalization
• Noninvasive ICP measurements
– MRI, ultrasound, OCT, tympanic membrane
displacement
©2014 MFMER | slide-52
Pseudopapilledema Papilledema
Ultrasound
MRI optic
nerve sheath
MRI sella
Patterson et al.
©2014 MFMER | slide-53
Selected Parameters Sensitivity Specificity
US ONSD 79.2 82.4
MRI ONSD 91.7 70.0
Pituitary/sella ratio 91.7 73.3
US ONSD & MRI pit/sella 70.8 100
MRI ONSD & MRI pit/sella 83.3 94.1
MRI ONSD or MRI pit/sella 100 64.7
US ONSD or MRI ONSD or MRI pit/sella 100 47.1
US ONSD & MRI ONSD & MRI pit/sella 66.7 100
(MRI ONSD or US ONSD) & MRI pit/sella 87.5 94.1
Sensitivity/Specificity Calculations
Ultrasound alone is fairly sensitive/specific
MRI alone has slightly better sensitivity/specificity
Combining ultrasound and MRI slightly increased sensitivity
Patterson et al.
©2014 MFMER | slide-54
23 yo with bilateral grade IV papilledema
from idiopathic intracranial hypertension
Patient underwent LP
Bruch’s membrane returns
to a more neutral position
OCT shows an upturned
Bruch’s membrane
Position of Bruch’s membrane on OCT correlates with intracranial pressure
©2014 MFMER | slide-55
The Rat Intraventricular Cannula model
ICP can be raised and lowered chronically. (model created by Dr. Fautch and Chowdhury)
Baseline OCT Increased ICP
©2014 MFMER | slide-56
Brain MR elastography:
Measuring stiffness of the brain
Compact 3 Tesla MRI
©2014 MFMER | slide-57
Inversion
0 40 80Shear Stiffness (kPa)
Elastogram
2.5cm
Driver
Conventional
MR Image
-10
Wave Images
MRE Acquisition
0 +10Displacement (mm)
Brain MR elastographyTechnique
©2014 MFMER | slide-58
Anatomic Elastogram
8
0
Stiffn
ess (k
Pa)
Wave Image
©2014 MFMER | slide-59
MR elastography to measure brain stiffness
Arvin Arania, Hoon-Ki Mina,b, Nikoo Fattahia, Nicholas M Wetjena, Joshua D Trzaskoa, Armando Manducac, Clifford
Jacka, Kendall H. Leeb, Richard L Ehmana, John Huston IIIa (manuscript submitted)
• Increasing ICP in a pig model resulted in stiffer brain
• We are currently enrolling patients in a clinical trial to evaluate
raised ICP using MR elastography with the compact 3 Tesla MRI
©2014 MFMER | slide-60
The Final Frontier: Space Flight-associated Neuro-ocular Syndrome (SANS)
N o (C P G 0 ) Y e s (C P G 1 -4 )
G G
AA/AG
O p h th a lm ic Is s u e s
MT
RR
A6
6G
• Many astronauts with papilledema were found to have specific
polymorphisms
• We have a grant with NASA to evaluate patients with IIH and
polycystic ovarian syndrome for these mutations
MTRR polymorphism
Astronaut Papilledema and One Carbon Metabolism
The Final Frontier: Space Flight-associated Neuro-ocular Syndrome (SANS)
The Final Frontier: Space Flight-associated Neuro-ocular Syndrome (SANS)
Zwart et al., 2019
The Final Frontier: Space Flight-associated Neuro-ocular Syndrome (SANS)
Zwart et al., 2019
©2014 MFMER | slide-64
Lower Body Negative Pressure Box
Potential treatment for space travel?
Non-metal version compatible with MRI
©2014 MFMER | slide-65
Summary
• IIH is a disease that affects young adult females,
often triggered by weight gain
– Must rule out other causes of raised ICP with
MRI/MRV + LP
– The incidence is rising with the increase in obesity
• Papilledema = disc edema from raised ICP
– Ddx includes Pseudopapilledema, malignant
hypertension, and others
©2014 MFMER | slide-66
Summary
• IIH is a disease that affects young adult females,
often triggered by weight gain
– Must rule out other causes of raised ICP with
MRI/MRV + LP
– The incidence is rising with the increase in obesity
• Papilledema = disc edema from raised ICP
– Ddx includes Pseudopapilledema, malignant
hypertension, and others: including Astronauts!
©2014 MFMER | slide-67
Questions & Discussion